Emmanuel Benjamin Walter Jr.

Emmanuel Benjamin Walter Jr.
Professor of Pediatrics

Dr. Emmanuel (Chip) Walter is Director of the Duke Vaccine and Trials Unit

Immunization research:

1) Phase 1, 2 and 3 vaccine trials including: pandemic and seasonal influenza virus vaccines, respiratory virus vaccines, rotavirus vaccine, human papilloma virus vaccine, conjugate pneumococcal vaccine, meningococcal vaccines, vaccines for biodefence; vaccines for emerging pathogens; combination vaccines; and vaccines containing novel adjuvants or using novel delivery systems

2) Vaccine utilization (vaccination of special populations, adolescent immunization)

3) Vaccine safety evaluations conducted though the Centers for Disease Control and Prevention Clinical Immunization Safety Assessment Project

Clinical trials aimed at the prevention and treatment of infectious diseases

Current Appointments & Affiliations

Professor of Pediatrics, Pediatrics, Primary Care Pediatrics, Pediatrics 2009
Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 1987
Member of the Duke Human Vaccine Institute, Duke Human Vaccine Institute, Institutes and Centers 2013

Contact Information

2608 Erwin Road, Suite 210, Durham, NC 27705
Box 3675 Med Ctr, Durham, NC 27710
walte002@mc.duke.edu (919) 620-5374

Background
Education, Training, & Certifications
- M.P.H., University of North Carolina at Chapel Hill 1992
- M.D., University of Maryland, College Park 1983
- B.S., University of Notre Dame 1979
Duke Appointment History
- Associate Professor of Pediatrics, Pediatrics, Primary Care Pediatrics, Pediatrics 2002 - 2009
- Associate Professor of Pediatrics, Pediatrics, Primary Care Pediatrics, Pediatrics 1998 - 2002
- Assistant Professor of Pediatrics, Pediatrics, Primary Care Pediatrics, Pediatrics 1992 - 1998
- Associate in the Department of Pediatrics, Pediatrics, Clinical Science Departments 1990 - 1992
Recognition
In the News
- JUN 19, 2015
  
  Duke Human Vaccine Team Awarded $5 million To Study Fungal Fever
- SEP 26, 2013
  
  Duke Medicine Selected as New Site for Competitive Vaccine and Treatment Research Program
Research
Selected Grants
- VTEU 14-0053 Task C Option 2 Protocol Implementation awarded by National Institutes of Health 2018 - 2024
- VTEU A-1 Admin awarded by National Institutes of Health 2013 - 2023
- VTEU Sample Task Orders awarded by National Institutes of Health 2013 - 2023
- CISA 2018-2019 - Clinical Consult - Base awarded by Centers for Disease Control and Prevention 2017 - 2022
- CISA 2017 06 - Clinical Consult - Base awarded by Centers for Disease Control and Prevention 2017 - 2022
- CISA 2017 06 - Clinical Consult - Opt 2 awarded by Centers for Disease Control and Prevention 2017 - 2022
- CISA 2018-2019 - Clinical Consult - Opt 2 awarded by Centers for Disease Control and Prevention 2017 - 2022
- RTOP 2018 CISA 01 Flublok Lead Base awarded by Centers for Disease Control and Prevention 2018 - 2021
- RTOP 2018 CISA 01 Flublok Lead Task 1 awarded by Centers for Disease Control and Prevention 2018 - 2021
- A tailored school-based intervention to increase vaccine uptake among adolescents in the rural South awarded by Centers for Disease Control and Prevention 2018 - 2021
- Research Training in Allergy and Clinical Immunology awarded by National Institutes of Health 2000 - 2021
- VTEU Task Order 18-0011.B1.C1.0116-Task C Option 1 awarded by National Institutes of Health 2019 - 2021
- VTEU: Task Area D: Research Laboratory Analysis Protocol #14-0053 awarded by National Institutes of Health 2015 - 2021
- CISA RTOP 2017-01 Apnea (Lead) - Option 1 awarded by Centers for Disease Control and Prevention 2017 - 2021
- VTEU 13-0053 Task Area C awarded by National Institutes of Health 2014 - 2020
- VTEU Task D Protocol FY.2015.D1B1C1.0032 awarded by National Institutes of Health 2015 - 2020
- VTEU RTOP FY.2017.B8C12.0080 - Task B awarded by National Institutes of Health 2017 - 2020
- VTEU RTOP FY.2017.B8C12.0080 - Task C - Option 1 awarded by National Institutes of Health 2017 - 2020
- VTEU RTOP FY.2017.B8C12.0080 - Task C - Option 3 awarded by National Institutes of Health 2017 - 2020
- VTEU RTOP FY.2017.B8C12.0080 - Task C - Option 8 awarded by National Institutes of Health 2017 - 2020
- VTEU Task Area D Option 9 Protocol FY.2016.D1.0026 awarded by National Institutes of Health 2017 - 2020
- VTEU Task Area C Option 3 Protocol FY.2016.C1.0026 awarded by National Institutes of Health 2016 - 2020
- VTEU Task Order 16-0058 - Task B awarded by National Institutes of Health 2017 - 2020
- VTEU Task Order 16-0058 - Task C awarded by National Institutes of Health 2017 - 2020
- VTEU Task Order 16-0058.B1C1D1.0076 - Task D awarded by National Institutes of Health 2017 - 2020
- VTEU Task C Option 2 Protocol 14-0079.B1C1.0028 awarded by National Institutes of Health 2017 - 2019
- VAC057: Assess the reactogenicity, safety, and immunogenicity of a live attenuated universal influenza vaccine awarded by PATH 2017 - 2019
- CISA RFTP 2017-03 Syncope Prevention Study (Lead) - Option 2 awarded by Centers for Disease Control and Prevention 2018 - 2019
- CISA: 2015 CISA 02 - Contributing Site Base Task: Consultation for the LAIV and Asthma Study (Contributing) awarded by Centers for Disease Control and Prevention 2015 - 2019
- CISA: 2015 CISA 02 - Contributing Site Optional Task 1: Enrollment and Data Collection for the LAIV and Asthma Study (Contributing) awarded by Centers for Disease Control and Prevention 2015 - 2019
- RFTP 2016 CISA 01 - Base - FLUAD vs. Fluzone® High-Dose Study (Lead) awarded by Centers for Disease Control and Prevention 2016 - 2019
- VTEU 18-0010.B1C1.0120_Task B Base awarded by National Institutes of Health 2019
- VTEU 14-0053 Task Area A Project Logistics and Site Activation awarded by National Institutes of Health 2018 - 2019
- VTEU Task D Option 1 Protocol FY.2015.A4D14.0033 awarded by National Institutes of Health 2015 - 2019
- VTEU Task D Option 2 Protocol FY.2015.A4D14.0033 awarded by National Institutes of Health 2015 - 2019
- VTEU Task D Option 3 Protocol FY.2015.A4D14.0033 awarded by National Institutes of Health 2015 - 2019
- VTEU Task D Option 4 Protocol FY.2015.A4D14.0033 awarded by National Institutes of Health 2015 - 2019
- VTEU: Task Area C: Protocol Implementation - Option 2 Protocol #14-0053 awarded by National Institutes of Health 2015 - 2019
- RFTP 2018 CISA 05 FLUAD Logical Follow On Task 1 awarded by Centers for Disease Control and Prevention 2018 - 2019
- VTEU Task Order 18-0011.B1.C1.0116-Task B Base awarded by National Institutes of Health 2018 - 2019
- VTEU RTOP FY.2019.A1B1C1D1.0103 - Task A - Base awarded by National Institutes of Health 2018 - 2019
- VTEU Task C Option 1 Protocol 15-0066.B1C1D1.0041 awarded by National Institutes of Health 2016 - 2019
- VTEU Task Area D Option 8B Protocol FY.2016.D1.0026 awarded by National Institutes of Health 2016 - 2019
- VTEU Task B Base Protocol 15-0066.B1C1D1.0041 awarded by National Institutes of Health 2016 - 2018
- IMPAACT trial awarded by Johns Hopkins University 2018
- VTEU Task Area D Option 8 Protocol FY.2016.D1.0026 awarded by National Institutes of Health 2016 - 2018
- CISA RFTP 2017-03 Syncope Prevention Study (Lead) - Base awarded by Centers for Disease Control and Prevention 2017 - 2018
- CISA RFTP 2017-03 Syncope Prevention Study (Lead) - Option 1 awarded by Centers for Disease Control and Prevention 2017 - 2018
- CISA: 2015 CISA 03 - Lead Site Optional Task 1: Additional Subjects for Maternal Tdap and IIV Study (Lead) awarded by Centers for Disease Control and Prevention 2016 - 2018
- CISA: 2015 CISA 03 - Lead Site Base Task: Maternal Tdap and IIV Study (Lead) awarded by Centers for Disease Control and Prevention 2015 - 2018
- CISA RTOP 2017-01 Apnea (Lead) - Base awarded by Centers for Disease Control and Prevention 2017 - 2018
- RFTP 2016 CISA 03 - Option 1 - Fever after Simultaneous Vaccination (Lead) awarded by Centers for Disease Control and Prevention 2017 - 2018
- VTEU Task Area C Option 3B Protocol FY.2016.C1.0026 awarded by National Institutes of Health 2016 - 2018
- VTEU FY.2018.A1B1C1D1.0077 - Task A - Option 1 awarded by National Institutes of Health 2017 - 2018
- VTEU FY.2018.A1B1C1D1.0077 Task Area A - Base awarded by National Institutes of Health 2017 - 2018
- VTEU Task B Option 2 - FY.2017.A1B1C1D1.0048 awarded by National Institutes of Health 2017 - 2018
- VTEU Task C Option 1 Protocol 14-0079.B1C1.0028 awarded by National Institutes of Health 2016 - 2018
- VTEU Task Order 16-0047 -Task C Option 1 awarded by National Institutes of Health 2018
- VTEU Task Order 16-0047.C1.0090 awarded by National Institutes of Health 2018
- VTEU Task Area C: Protocal implementation for protocal # 13-0020 awarded by National Institutes of Health 2014 - 2018
- VTEU: Base -Task Area A: Project Logistics and Site Activation Protocol #14-0053 awarded by National Institutes of Health 2015 - 2017
- RFTP 2016 CISA 03 - Base - Fever after simultaneous vaccination (Lead) awarded by Centers for Disease Control and Prevention 2016 - 2017
- VTEU Task Area B Option 2 Protocol FY.2016.B1.0026 awarded by National Institutes of Health 2016 - 2017
- CISA Clinical Consult TO I - Option 4 awarded by Centers for Disease Control and Prevention 2016 - 2017
- CISA Task Order No. 3 Tdap Safety in Pregnant Women Infant Option Task 1-CLIN0002 awarded by Centers for Disease Control and Prevention 2014 - 2017
- VTEU Task A Option 1 - FY.2017.A1B1C1D1.0048 awarded by National Institutes of Health 2017
- VTEU Task A Base - FY.2017.A1B1C1D1.0048 awarded by National Institutes of Health 2016 - 2017
- CISA Task Order No. 3 Tdap Safety in Pregnant Women Infant Option Task 2-CLIN0003 awarded by Centers for Disease Control and Prevention 2014 - 2017
- VTEU Task Area B Option 2 Protocol FY.2016.B1.0026 awarded by National Institutes of Health 2016 - 2017
- VTEU Task B Base Protocol 14-0079.B1C1.0028 awarded by National Institutes of Health 2015 - 2016
- Option Three (3) of Contract No. 200-2012-53663, Task Order 0001 awarded by Centers for Disease Control and Prevention 2015 - 2016
- CISA TO2 Prophylactic Antipyretics Revision 1-A awarded by Centers for Disease Control and Prevention 2014 - 2016
- CISA TO2 Prophylactic Antipyretics Revision 3-A awarded by Centers for Disease Control and Prevention 2014 - 2016
- CISA Task Order No. 3 Tdap Safety in Pregnant Women awarded by Centers for Disease Control and Prevention 2013 - 2016
- VTEU Task A Protocol FY.2015.A4D14.0033 awarded by National Institutes of Health 2015 - 2016
- Subcontract: Comparing Traditional and Participatory Dissemination of a Shared Decision Making Intervention awarded by Carolinas HealthCare System 2013 - 2016
- CISA TO2 Prophylactic Antipyretics awarded by Centers for Disease Control and Prevention 2013 - 2016
- VTEU Task Area A, Base Protocol FY.2016.A1.0026 awarded by National Institutes of Health 2015 - 2016
- VTEU: Option 1-Task Area B: Protocol Development Protocol #14-0053 awarded by National Institutes of Health 2015 - 2016
- Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development awarded by National Institutes of Health 2014 - 2015
- Multiscale Systems Immunology awarded by National Institutes of Health 2010 - 2015
- VTEU Task Area A - FY.2015.A1.0016 Base awarded by National Institutes of Health 2014 - 2015
- Clinical Trial Services Agreement with bioCSL to Study the Performance of CSL Trivalent Influenza Vaccine awarded by ACCELOVANCE, INC. 2014 - 2015
- VTEU 12-0016: Task Area C: Protocol implementation awarded by National Institutes of Health 2014 - 2015
- VTEU 13-0053 Task Area B awarded by National Institutes of Health 2014 - 2015
- CISA-Task Order 1: Option 1 awarded by Centers for Disease Control and Prevention 2013 - 2014
- CISA awarded by Centers for Disease Control and Prevention 2012 - 2013
- DMID 05-0048 Tdap Vaccine in Pregnant Women awarded by University of Maryland 2010 - 2012
- Effectiveness of a Vaccination Program in the Community ObGyn Setting awarded by Centers for Disease Control and Prevention 2008 - 2011
- A randomized double-blind trial on the safety and immunogenicity of inactivated trivalent influenza vaccine in pregnant awarded by University of Maryland 2009 - 2010
- PiiiTCH Study awarded by Centers for Disease Control and Prevention 2006 - 2009
- Preschool Vision Screening in Primary Care Settings awarded by National Institutes of Health 2003 - 2008
- Implementing Research Findings for Practice Improvement awarded by National Institutes of Health 2002 - 2006
- Epidemiologic Research Studies of AIDS and HIV Infection awarded by National Institutes of Health 1998 - 2000
- Epidemiologic Research Studies Of Aids And Hiv Infection awarded by National Institutes of Health 1995 - 1998
- Evaluation Of Perinatal Hiv Prevention In North Carolina awarded by National Institutes of Health 1995 - 1998
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Edwards, James M., Nora Watson, Chris Focht, Clara Wynn, Christopher A. Todd, Emmanuel B. Walter, R Phillips Heine, and Geeta K. Swamy. “Group B Streptococcus (GBS) Colonization and Disease among Pregnant Women: A Historical Cohort Study..” Infectious Diseases in Obstetrics and Gynecology 2019 (January 2019). https://doi.org/10.1155/2019/5430493.
    Full Text Open Access Copy
  - Fortner, Kimberly B., Geeta K. Swamy, Karen R. Broder, Natalia Jimenez-Truque, Yuwei Zhu, Pedro L. Moro, Jennifer Liang, et al. “Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women..” Vaccine 36, no. 42 (October 2018): 6354–60. https://doi.org/10.1016/j.vaccine.2018.07.012.
    Full Text
  - Grohskopf, Lisa A., Leslie Z. Sokolow, Karen R. Broder, Emmanuel B. Walter, Alicia M. Fry, and Daniel B. Jernigan. “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season..” Mmwr. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports 67, no. 3 (August 24, 2018): 1–20. https://doi.org/10.15585/mmwr.rr6703a1.
    Full Text
  - Brady, Rebecca C., Lisa A. Jackson, Sharon E. Frey, Andi L. Shane, Emmanuel B. Walter, Geeta K. Swamy, Elizabeth P. Schlaudecker, et al. “Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women..” Vaccine 36, no. 31 (July 2018): 4663–71. https://doi.org/10.1016/j.vaccine.2018.06.036.
    Full Text
  - Grohskopf, Lisa A., Leslie Z. Sokolow, Alicia M. Fry, Emmanuel B. Walter, and Daniel B. Jernigan. “Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018-19 Influenza Season..” Mmwr Morb Mortal Wkly Rep 67, no. 22 (June 8, 2018): 643–45. https://doi.org/10.15585/mmwr.mm6722a5.
    Full Text Link to Item
  - Belongia, Edward A., Ruth A. Karron, Arthur Reingold, Emmanuel B. Walter, and Nancy M. Bennett. “The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder.” Vaccine 36, no. 3 (January 8, 2018): 343–44.
    Link to Item
  - Belongia, Edward A., Ruth A. Karron, Arthur Reingold, Emmanuel B. Walter, and Nancy M. Bennett. “The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder..” Vaccine 36, no. 3 (January 2018): 343–44. https://doi.org/10.1016/j.vaccine.2017.06.017.
    Full Text
  - Walter, Emmanuel B., Christoph P. Hornik, Lisa Grohskopf, Charles E. McGee, Christopher A. Todd, Oidda I. Museru, Lynn Harrington, and Karen R. Broder. “The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children..” Vaccine 35, no. 48 Pt B (December 2017): 6664–71. https://doi.org/10.1016/j.vaccine.2017.10.020.
    Full Text
  - Grohskopf, L. A., L. Z. Sokolow, K. R. Broder, E. B. Walter, J. S. Bresee, A. M. Fry, and D. B. Jernigan. “Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2017-18 Influenza Season..” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 17, no. 11 (November 2017): 2970–82. https://doi.org/10.1111/ajt.14511.
    Full Text
  - Kemper, Alex R., Elizabeth D. Barnett, Emmanuel B. Walter, Christoph Hornik, Natalie Pierre-Joseph, Karen R. Broder, Michael Silverstein, and Theresa Harrington. “Drinking Water to Prevent Postvaccination Presyncope in Adolescents: A Randomized Trial..” Pediatrics 140, no. 5 (November 2017). https://doi.org/10.1542/peds.2017-0508.
    Full Text
  - Grohskopf, Lisa A., Leslie Z. Sokolow, Karen R. Broder, Emmanuel B. Walter, Joseph S. Bresee, Alicia M. Fry, and Daniel B. Jernigan. “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season..” Mmwr. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports 66, no. 2 (August 25, 2017): 1–20. https://doi.org/10.15585/mmwr.rr6602a1.
    Full Text
  - Grohskopf, Lisa A., Leslie Z. Sokolow, Karen R. Broder, Emmanuel B. Walter, Joseph S. Bresee, Alicia M. Fry, and Daniel B. Jernigan. “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.” Mmwr Recommendations and Reports 66, no. 2 (August 25, 2017): 3–21.
    Link to Item
  - Saleh, Ezzeldin, Geeta K. Swamy, M Anthony Moody, and Emmanuel B. Walter. “Parental Approach to the Prevention and Management of Fever and Pain Following Childhood Immunizations: A Survey Study..” Clinical Pediatrics 56, no. 5 (May 2017): 435–42. https://doi.org/10.1177/0009922816675116.
    Full Text
  - Fuller, Jill E., Emmanuel B. Walter, Nancy Dole, Richard O’Hara, Amy H. Herring, Maureen S. Durkin, Bonny Specker, and Betty Wey. “State-Level Immunization Information Systems: Potential for Childhood Immunization Data Linkages..” Maternal and Child Health Journal 21, no. 1 (January 2017): 29–35. https://doi.org/10.1007/s10995-016-2090-1.
    Full Text
  - Saleh, Ezzeldin, M Anthony Moody, and Emmanuel B. Walter. “Effect of antipyretic analgesics on immune responses to vaccination..” Human Vaccines & Immunotherapeutics 12, no. 9 (September 2016): 2391–2402. https://doi.org/10.1080/21645515.2016.1183077.
    Full Text
  - Walter, Emmanuel B., and Mary Allen Staat. “Rotavirus Vaccine and Intussusception Hospitalizations..” Pediatrics 138, no. 3 (September 2016). https://doi.org/10.1542/peds.2016-1952.
    Full Text
  - Libster, Romina, Monica McNeal, Emmanuel B. Walter, Andi L. Shane, Patricia Winokur, Gretchen Cress, Andrea A. Berry, et al. “Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules..” Pediatrics 137, no. 2 (February 2016). https://doi.org/10.1542/peds.2015-2603.
    Full Text
  - Mbawuike, Innocent N., Robert L. Atmar, Shital M. Patel, David B. Corry, Patricia L. Winokur, Rebecca C. Brady, Wilbur H. Chen, et al. “Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine..” Vaccine 34, no. 4 (January 2016): 547–54. https://doi.org/10.1016/j.vaccine.2015.11.055.
    Full Text
  - Weiss, Thomas, Dongmu Zhang, Nagesh N. Borse, and Emmanuel B. Walter. “Initiation & completion rates of hepatitis A vaccination among US pediatric populations born between 2005 and 2009..” Vaccine 33, no. 48 (November 2015): 6871–77. https://doi.org/10.1016/j.vaccine.2015.07.065.
    Full Text
  - Winokur, Patricia L., Shital M. Patel, Rebecca Brady, Wilbur H. Chen, Samer S. El-Kamary, Kathryn Edwards, C Buddy Creech, et al. “Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine..” The Journal of Infectious Diseases 212, no. 4 (August 2015): 525–30. https://doi.org/10.1093/infdis/jiv087.
    Full Text
  - Chung, Richard J., Emmanuel B. Walter, Alex R. Kemper, and Amanda Dayton. “Keen on teen vaccines: improvement of adolescent vaccine coverage in rural North Carolina..” The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine 56, no. 5 Suppl (May 2015): S14–16. https://doi.org/10.1016/j.jadohealth.2014.10.272.
    Full Text
  - Russell, Kate, Eileen F. Dunne, Alex R. Kemper, Rowena J. Dolor, Elizabeth R. Unger, Gitika Panicker, Lauri E. Markowitz, and Emmanuel B. Walter. “Antibody responses among adolescent females receiving the quadrivalent HPV vaccine series corresponding to standard or non-standard dosing intervals..” Vaccine 33, no. 16 (April 2015): 1953–58. https://doi.org/10.1016/j.vaccine.2015.02.058.
    Full Text
  - Walter, Emmanuel B., Alex R. Kemper, Rowena J. Dolor, and Eileen F. Dunne. “Pain in adolescent girls receiving human papillomavirus vaccine with concomitantly administered vaccines..” The Pediatric Infectious Disease Journal 34, no. 2 (February 2015): 200–202. https://doi.org/10.1097/inf.0000000000000537.
    Full Text
  - Walter, E. B., A. R. Kemper, R. J. Dolor, and E. F. Dunne. “Pain in adolescent girls receiving human papillomavirus vaccine with concomitantly administered vaccines.” Journal of Pediatric Infectious Diseases 34, no. 2 (January 1, 2015): 200–202. https://doi.org/10.1097/INF.0000000000000537.
    Full Text
  - “Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2014-15 Influenza Season.” American Journal of Transplantation 14, no. 12 (December 2014): 2906–13. https://doi.org/10.1111/ajt.13065.
    Full Text
  - Belshe, Robert B., Sharon E. Frey, Irene L. Graham, Edwin L. Anderson, Lisa A. Jackson, Paul Spearman, Srilatha Edupuganti, et al. “Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial..” Jama 312, no. 14 (October 2014): 1420–28. https://doi.org/10.1001/jama.2014.12609.
    Full Text
  - Callahan, S Todd, Mark Wolff, Heather R. Hill, Kathryn M. Edwards, and Kathryn M. NIAID Vaccine and Treatment Evaluation Unit (VTEU) Pandemic H1N1 Vaccine Study Group. “Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults..” The Journal of Infectious Diseases 210, no. 8 (October 2014): 1270–74. https://doi.org/10.1093/infdis/jiu245.
    Full Text
  - Kepler, Thomas B., Hua-Xin Liao, S Munir Alam, Rekha Bhaskarabhatla, Ruijun Zhang, Chandri Yandava, Shelley Stewart, et al. “Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies..” Cell Host & Microbe 16, no. 3 (September 2014): 304–13. https://doi.org/10.1016/j.chom.2014.08.006.
    Full Text
  - Grohskopf, Lisa A., Sonja J. Olsen, Leslie Z. Sokolow, Joseph S. Bresee, Nancy J. Cox, Karen R. Broder, Ruth A. Karron, Emmanuel B. Walter, and Emmanuel B. Centers for Disease Control and Prevention. “Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season..” Mmwr. Morbidity and Mortality Weekly Report 63, no. 32 (August 2014): 691–97.
  - Kotloff, Karen L., Natasha B. Halasa, Christopher J. Harrison, Janet A. Englund, Emmanuel B. Walter, James C. King, C Buddy Creech, et al. “Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children..” The Pediatric Infectious Disease Journal 33, no. 8 (August 2014): 865–71. https://doi.org/10.1097/INF.0000000000000329.
    Full Text
  - Jackson, K. J. L., Y. Liu, K. M. Roskin, J. Glanville, R. A. Hoh, K. Seo, E. L. Marshall, et al. “Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements.” Cell Host and Microbe 16, no. 1 (July 9, 2014): 105–14. https://doi.org/10.1016/j.chom.2014.05.013.
    Full Text
  - Jackson, Katherine J. L., Yi Liu, Krishna M. Roskin, Jacob Glanville, Ramona A. Hoh, Katie Seo, Eleanor L. Marshall, et al. “Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements..” Cell Host & Microbe 16, no. 1 (July 2014): 105–14. https://doi.org/10.1016/j.chom.2014.05.013.
    Full Text
  - Munoz, Flor M., Nanette H. Bond, Maurizio Maccato, Phillip Pinell, Hunter A. Hammill, Geeta K. Swamy, Emmanuel B. Walter, et al. “Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial..” Jama 311, no. 17 (May 2014): 1760–69. https://doi.org/10.1001/jama.2014.3633.
    Full Text
  - Steiner, Brian, Geeta K. Swamy, and Emmanuel B. Walter. “Engaging expectant parents to receive Tdap vaccination..” American Journal of Perinatology 31, no. 5 (May 2014): 407–12. https://doi.org/10.1055/s-0033-1352483.
    Full Text
  - Specker, Bonny, Betty Wey, Jill Fuller, Marie-Noel Sandoval, Maureen Durkin, Nancy Dole, and Emmanuel B. Walter. “2009 H1N1 and seasonal influenza immunization among pregnant women: a comparison of different sources of immunization information..” Maternal and Child Health Journal 18, no. 3 (April 2014): 681–87. https://doi.org/10.1007/s10995-013-1293-y.
    Full Text
  - Munoz, F. M., N. H. Bond, M. Maccato, P. Pinell, H. A. Hammill, G. K. Swamy, E. B. Walter, et al. “Safety and immunogenicity of tetanus, diphtheria, and acellular pertussis immunization during pregnancy in mothers and infants: A randomized clinical trial.” Obstetrical and Gynecological Survey 69, no. 9 (January 1, 2014): 517–19. https://doi.org/10.1097/OGX.0000000000000101.
    Full Text
  - Specker, B., B. Wey, J. Fuller, M. N. Sandoval, M. Durkin, N. Dole, and E. B. Walter. “2009 H1N1 and seasonal influenza immunization among pregnant women: A comparison of different sources of immunization information.” Maternal and Child Health Journal 18, no. 3 (January 1, 2014): 681–87. https://doi.org/10.1007/s10995-013-1293-y.
    Full Text
  - Steiner, B., G. K. Swamy, and E. B. Walter. “Engaging expectant parents to receive Tdap vaccination.” American Journal of Perinatology 31, no. 5 (January 1, 2014): 407–12. https://doi.org/10.1055/s-0033-1352483.
    Full Text
  - Walter, Emmanuel B., and Dennis A. Clements. “Pneumococcal conjugate vaccine: are 3 doses equal to 4 doses?.” Pediatrics 132, no. 2 (August 2013): e498–99. https://doi.org/10.1542/peds.2013-1573.
    Full Text
  - Frey, Sharon E., Patricia L. Winokur, Robert A. Salata, Samer S. El-Kamary, Christine B. Turley, Emmanuel B. Walter, Christine Mhorag Hay, et al. “Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario..” Vaccine 31, no. 29 (June 2013): 3025–33. https://doi.org/10.1016/j.vaccine.2013.04.050.
    Full Text
  - Walter, Emmanuel B., and Richard J. Chung. “Immunizations for preteens..” North Carolina Medical Journal 74, no. 1 (January 2013): 66–71.
  - Chen, Wilbur H., Patricia L. Winokur, Kathryn M. Edwards, Lisa A. Jackson, Anna Wald, Emmanuel B. Walter, Diana L. Noah, Mark Wolff, Karen L. Kotloff, and Karen L. Pandemic H1N1 Vaccine Adult Study Group. “Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009..” Vaccine 30, no. 28 (June 2012): 4240–48. https://doi.org/10.1016/j.vaccine.2012.04.044.
    Full Text
  - Dolinsky, Diana H., Sarah C. Armstrong, Emmanuel B. Walter, and Alex R. Kemper. “The effectiveness of a primary care-based pediatric obesity program..” Clinical Pediatrics 51, no. 4 (April 2012): 345–53. https://doi.org/10.1177/0009922811425232.
    Full Text
  - Hauber, A Brett, Robbin Itzler, F Reed Johnson, Ateesha F. Mohamed, Juan Marcos González, John R. Cook, and Emmanuel B. Walter. “Healthy-days time equivalents for outcomes of acute rotavirus infections..” Vaccine 29, no. 45 (October 2011): 8086–93. https://doi.org/10.1016/j.vaccine.2011.08.041.
    Full Text
  - Whittle, James R. R., Ruijun Zhang, Surender Khurana, Lisa R. King, Jody Manischewitz, Hana Golding, Philip R. Dormitzer, et al. “Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin..” Proc Natl Acad Sci U S A 108, no. 34 (August 23, 2011): 14216–21. https://doi.org/10.1073/pnas.1111497108.
    Full Text Link to Item
  - Frenck, Robert W., Robert Belshe, Rebecca C. Brady, Patricia L. Winokur, James D. Campbell, John Treanor, Christine M. Hay, et al. “Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults..” Vaccine 29, no. 34 (August 2011): 5666–74. https://doi.org/10.1016/j.vaccine.2011.06.010.
    Full Text
  - “A statement regarding personal belief exemption from immunization mandates: from the Pediatric Infectious Diseases Society, March 2011..” The Pediatric Infectious Disease Journal 30, no. 7 (July 2011): 606–7. https://doi.org/10.1097/inf.0b013e318224949e.
    Full Text
  - Tan, Weiyi, Anthony J. Viera, Beth Rowe-West, Amy Grimshaw, Beth Quinn, and Emmanuel B. Walter. “The HPV vaccine: are dosing recommendations being followed?.” Vaccine 29, no. 14 (March 2011): 2548–54. https://doi.org/10.1016/j.vaccine.2011.01.066.
    Full Text
  - Walter, Emmanuel B., Nancy Dole, Anna Maria Siega-Riz, and Barbara Entwisle. “The National Children's Study in North Carolina: a study of the effect of the environment on children's health, growth, and development..” North Carolina Medical Journal 72, no. 2 (March 2011): 160–64.
  - Moody, M Anthony, Ruijun Zhang, Emmanuel B. Walter, Christopher W. Woods, Geoffrey S. Ginsburg, Micah T. McClain, Thomas N. Denny, et al. “H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination..” Plos One 6, no. 10 (2011). https://doi.org/10.1371/journal.pone.0025797.
    Full Text Link to Item
  - Kemper, A. R., E. Landolfo, and E. B. Walter. “Special considerations of medication adherence in childhood and adolescence,” December 1, 2010, 311–20. https://doi.org/10.1007/978-1-4419-5866-2_13.
    Full Text
  - Halperin, Scott A., Anil Gupta, Robert Jeanfreau, Nicola P. Klein, Keith Reisinger, Emmanuel Walter, Lisa Bedell, Christopher Gill, and Peter M. Dull. “Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age..” Vaccine 28, no. 50 (November 2010): 7865–72. https://doi.org/10.1016/j.vaccine.2010.09.092.
    Full Text
  - Walter, Emmanuel B., Norma J. Allred, Geeta K. Swamy, Anne S. Hellkamp, and Rowena J. Dolor. “Influenza vaccination of household contacts of newborns: a hospital-based strategy to increase vaccination rates..” Infection Control and Hospital Epidemiology 31, no. 10 (October 2010): 1070–73. https://doi.org/10.1086/656563.
    Full Text Open Access Copy
  - Walter, Emmanuel B., Shilpa Rajagopal, Yuwei Zhu, Kathleen M. Neuzil, Mary P. Fairchok, and Janet A. Englund. “Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally?.” Vaccine 28, no. 27 (June 2010): 4376–83. https://doi.org/10.1016/j.vaccine.2010.04.058.
    Full Text
  - Englund, Janet A., Emmanuel Walter, Steven Black, Mark Blatter, Jack Nyberg, Frederick L. Ruben, Michael D. Decker, and Michael D. GRC28 Study Team. “Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study..” The Pediatric Infectious Disease Journal 29, no. 2 (February 2010): 105–10. https://doi.org/10.1097/inf.0b013e3181b84c34.
    Full Text
  - Mast, T Christopher, Emmanuel B. Walter, Monique Bulotsky, Shazia S. Khawaja, Daniel J. DiStefano, Mary K. Sandquist, Walter L. Straus, and Mary Allen Staat. “Burden of childhood rotavirus disease on health systems in the United States..” The Pediatric Infectious Disease Journal 29, no. 2 (February 2010): e19–25. https://doi.org/10.1097/inf.0b013e3181ca7e2e.
    Full Text
  - Mast, T. C., E. B. Walter, M. Bulotsky, S. S. Khawaja, D. J. Distefano, M. K. Sandquist, W. L. Straus, and M. Allen Staat. “Burden of childhood rotavirus disease on health systems in the united states: Results from active surveillance before rotavirus vaccine introduction.” Pediatric Infectious Disease Journal 29, no. 2 (January 1, 2010). https://doi.org/10.1097/INF.0b013e3181ca7e2e.
    Full Text
  - Walter, Emmanuel B., Janet A. Englund, Mark Blatter, Jack Nyberg, Frederick L. Ruben, Michael D. Decker, and Michael D. GRC27 Study Team. “Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study..” The Pediatric Infectious Disease Journal 28, no. 12 (December 2009): 1099–1104. https://doi.org/10.1097/inf.0b013e3181b0c0ca.
    Full Text
  - Walter, Emmanuel B., Norma Allred, Beth Rowe-West, Kathlene Chmielewski, Katrina Kretsinger, and Rowena J. Dolor. “Cocooning infants: Tdap immunization for new parents in the pediatric office..” Academic Pediatrics 9, no. 5 (September 2009): 344–47. https://doi.org/10.1016/j.acap.2009.05.027.
    Full Text
  - Liao, Hua-Xin, Marc C. Levesque, Ashleigh Nagel, Ashlyn Dixon, Ruijun Zhang, Emmanuel Walter, Robert Parks, et al. “High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies..” Journal of Virological Methods 158, no. 1–2 (June 2009): 171–79. https://doi.org/10.1016/j.jviromet.2009.02.014.
    Full Text
  - Mast, T Christopher, Carla DeMuro-Mercon, Claudia M. Kelly, Leigh Ellen Floyd, and Emmanuel B. Walter. “The impact of rotavirus gastroenteritis on the family..” Bmc Pediatrics 9 (January 2009). https://doi.org/10.1186/1471-2431-9-11.
    Full Text
  - Keitel, Wendy A., James D. Campbell, John J. Treanor, Emmanuel B. Walter, Shital M. Patel, Fenhua He, Diana L. Noah, and Heather Hill. “Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial..” J Infect Dis 198, no. 9 (November 1, 2008): 1309–16. https://doi.org/10.1086/592172.
    Full Text Link to Item
  - Walter, Emmanuel B., Martha A. Snyder, Dennis A. Clements, and Samuel L. Katz. “Large injection site reactions after a second dose of varicella vaccine..” The Pediatric Infectious Disease Journal 27, no. 8 (August 2008): 757–59. https://doi.org/10.1097/inf.0b013e31816fc323.
    Full Text
  - Talbot, H Keipp, Wendy Keitel, Thomas R. Cate, John Treanor, James Campbell, Rebecca C. Brady, Irene Graham, et al. “Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine..” Vaccine 26, no. 32 (July 2008): 4057–61. https://doi.org/10.1016/j.vaccine.2008.05.024.
    Full Text
  - Walter, E. B., A. S. Hellkamp, K. C. Goldberg, D. Montgomery, B. Patterson, and R. J. Dolor. “Improving influenza vaccine coverage among asthmatics: A practice-based research network study.” Journal of Clinical Outcomes Management 15, no. 5 (May 1, 2008): 227–34.
  - Walter, E. B., H. Yang, and R. J. Dolor. “Low rates of adherence to 1999 acute otitis media treatment guidelines across pediatric and family practices.” Journal of Clinical Outcomes Management 14, no. 11 (November 1, 2007): 595–600.
  - Guerra, Fernando A., Jacqueline Gress, Alan Werzberger, Keith Reisinger, Emmanuel Walter, Hassan Lakkis, Anthony D. Grosso, Carolee Welebob, Barbara J. Kuter, and Barbara J. Pediatric Study Group for VAQTA. “Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children..” The Pediatric Infectious Disease Journal 25, no. 10 (October 2006): 912–19. https://doi.org/10.1097/01.inf.0000238135.01287.b9.
    Full Text
  - Englund, Janet A., Emmanuel B. Walter, Adepeju Gbadebo, Arnold S. Monto, Yuwei Zhu, and Kathleen M. Neuzil. “Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers..” Pediatrics 118, no. 3 (September 2006): e579–85. https://doi.org/10.1542/peds.2006-0201.
    Full Text
  - Kuter, Barbara J., Michelle L Hoffman Brown, Jonathan Hartzel, Wendy R. Williams, A. EvesiKaren, Steve Black, Henry Shinefield, et al. “Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad)..” Human Vaccines 2, no. 5 (September 2006): 205–14. https://doi.org/10.4161/hv.2.5.3246.
    Full Text
  - Walter, Emmanuel B., Kathleen M. Neuzil, Yuwei Zhu, Mary P. Fairchok, Martha E. Gagliano, Arnold S. Monto, and Janet A. Englund. “Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?.” Pediatrics 118, no. 3 (September 2006): e570–78. https://doi.org/10.1542/peds.2006-0198.
    Full Text
  - Stout, J. E., T. Ostbye, E. B. Walter, and C. D. Hamilton. “Tuberculosis knowledge and attitudes among physicians who treat young children in North Carolina, USA..” The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union Against Tuberculosis and Lung Disease 10, no. 7 (July 2006): 783–88.
  - Green, Michael D., Bernard Beall, Mario J. Marcon, Coburn H. Allen, John S. Bradley, Barry Dashefsky, Janet R. Gilsdorf, et al. “Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA..” The Journal of Antimicrobial Chemotherapy 57, no. 6 (June 2006): 1240–43. https://doi.org/10.1093/jac/dkl101.
    Full Text
  - Green, Michael, Coburn Allen, John Bradley, Barry Dashefsky, Janet R. Gilsdorf, Mario J. Marcon, Gordon E. Schutze, et al. “In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States..” Antimicrobial Agents and Chemotherapy 49, no. 6 (June 2005): 2487–89. https://doi.org/10.1128/AAC.49.6.2487-2489.2005.
    Full Text
  - Englund, Janet A., Emmanuel B. Walter, Mary P. Fairchok, Arnold S. Monto, and Kathleen M. Neuzil. “A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children..” Pediatrics 115, no. 4 (April 2005): 1039–47. https://doi.org/10.1542/peds.2004-2373.
    Full Text
  - Friedman, Joëlle Y., Shelby D. Reed, Kevin P. Weinfurt, Kristijan H. Kahler, Emmanuel B. Walter, and Kevin A. Schulman. “Parents' reported preference scores for childhood atopic dermatitis disease states..” Bmc Pediatrics 4, no. 1 (October 18, 2004). https://doi.org/10.1186/1471-2431-4-21.
    Full Text
  - Blaney, Nancy T., M Isabel Fernandez, Kathleen A. Ethier, Tracey E. Wilson, Emmanuel Walter, Linda J. Koenig, and Linda J. Perinatal Guidelines Evaluation Project Group. “Psychosocial and behavioral correlates of depression among HIV-infected pregnant women..” Aids Patient Care and Stds 18, no. 7 (July 2004): 405–15. https://doi.org/10.1089/1087291041518201.
    Full Text
  - Benjamin, D. K., W. C. Miller, R. W. Ryder, D. J. Weber, E. Walter, and R. E. McKinney. “Growth patterns reflect response to antiretroviral therapy in HIV-positive infants: potential utility in resource-poor settings..” Aids Patient Care and Stds 18, no. 1 (January 2004): 35–43. https://doi.org/10.1089/108729104322740901.
    Full Text
  - Benjamin, Daniel K., Wiliam C. Miller, Robert W. Ryder, David J. Weber, Emmanuel Walter, and Ross E. McKinney. “A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV..” Aids 17, no. 16 (November 7, 2003): 2331–36. https://doi.org/10.1097/01.aids.0000076347.42412.de.
    Full Text Link to Item
  - Wilson, Tracey E., Linda J. Koenig, Emmanual Walter, Isabel Fernandez, Kathleen Ethier, and Kathleen Perinatal Guidelines Evaluation Project. “Dual contraceptive method use for pregnancy and disease prevention among HIV-infected and HIV-uninfected women: the importance of an event-level focus for promoting safer sexual behaviors..” Sexually Transmitted Diseases 30, no. 11 (November 2003): 809–12. https://doi.org/10.1097/01.olq.0000086617.41012.14.
    Full Text
  - Clark, H Fred, Carl J. Burke, David B. Volkin, Paul Offit, Richard L. Ward, Joseph S. Bresee, Penelope Dennehy, et al. “Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation..” The Pediatric Infectious Disease Journal 22, no. 10 (October 2003): 914–20. https://doi.org/10.1097/01.inf.0000091887.48999.77.
    Full Text
  - Wilson, Tracey E., Linda Koenig, Jeannette Ickovics, Emmanuel Walter, Amy Suss, M Isabel Fernandez, and M Isabel Perinatal Guidelines Evaluation Project. “Contraception use, family planning, and unprotected sex: few differences among HIV-infected and uninfected postpartum women in four US states..” Journal of Acquired Immune Deficiency Syndromes (1999) 33, no. 5 (August 2003): 608–13. https://doi.org/10.1097/00126334-200308150-00010.
    Full Text
  - Parnes, Curt, Judith Guillermin, Rolf Habersang, Peggy Nicholes, Vijay Chawla, Tammy Kelly, Judith Fishbein, et al. “Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry..” Pediatric Pulmonology 35, no. 6 (June 2003): 484–89. https://doi.org/10.1002/ppul.10288.
    Full Text
  - Royce, R. A., E. B. Walter, M. I. Fernandez, T. E. Wilson, J. R. Ickovics, R. J. Simonds, and R. J. Perinatal Guidelines Evaluation Project. “Barriers to universal prenatal HIV testing in 4 US locations in 1997..” Am J Public Health 91, no. 5 (May 2001): 727–33.
    Link to Item
  - Wilson, T. E., J. R. Ickovics, M. I. Fernandez, L. J. Koenig, E. Walter, and E. Perinatal Guidelines Evaluation Project. “Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states..” American Journal of Obstetrics and Gynecology 184, no. 6 (May 2001): 1235–40. https://doi.org/10.1067/mob.2001.114032.
    Full Text
  - Clements, D. A., J. I. Zaref, C. L. Bland, E. B. Walter, and P. M. Coplan. “Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina..” Archives of Pediatrics & Adolescent Medicine 155, no. 4 (April 2001): 455–61. https://doi.org/10.1001/archpedi.155.4.455.
    Full Text
  - Walter, E. B., R. A. Royce, M. I. Fernández, J. DeHovitz, J. R. Ickovics, M. A. Lampe, and M. A. Perinatal Guidelines Evaluation Project group. “New mothers' knowledge and attitudes about perinatal human immunodeficiency virus infection..” Obstetrics and Gynecology 97, no. 1 (January 2001): 70–76. https://doi.org/10.1016/s0029-7844(00)01070-x.
    Full Text
  - Ickovics, J. R., K. A. Ethier, L. J. Koenig, T. E. Wilson, E. B. Walter, and M. I. Fernandez. “Infant birth weight among women with or at high risk for HIV infection: the impact of clinical, behavioral, psychosocial, and demographic factors..” Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association 19, no. 6 (November 2000): 515–23. https://doi.org/10.1037//0278-6133.19.6.515.
    Full Text
  - Fernández, M. I., T. E. Wilson, K. A. Ethier, E. B. Walter, C. L. Gay, and J. Moore. “Acceptance of HIV testing during prenatal care. Perinatal Guidelines Evaluation Project..” Public Health Reports (Washington, D.C. : 1974) 115, no. 5 (September 2000): 460–68. https://doi.org/10.1093/phr/115.5.460.
    Full Text
  - Frey, S., R. Dagan, Y. Ashur, X. Q. Chen, J. Ibarra, H. Kollaritsch, M. H. Mazur, et al. “Reply.” The Journal of Infectious Diseases 182, no. 3 (September 2000): 1005–6. https://doi.org/10.1086/315793.
    Full Text
  - Napravnik, S., R. Royce, E. Walter, and W. Lim. “HIV-1 infected women and prenatal care utilization: barriers and facilitators..” Aids Patient Care and Stds 14, no. 8 (August 2000): 411–20. https://doi.org/10.1089/108729100416623.
    Full Text
  - Clements, D. A., J. I. Zaref, P. M. Coplan, C. L. Bland, and E. B. Walter. “Decreased incidence of varicella in day care children after the initiation of varicella vaccination: A herd immunity effect?.” Clinical Infectious Diseases 31, no. 1 (July 1, 2000): 323–323.
    Link to Item
  - Abraham, B., D. Parenti, S. Frey, R. Dagan, Y. Ashur, X. Q. Chen, J. Ibarra, et al. “Antibody production in response to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine [1] (multiple letters).” Journal of Infectious Diseases 182, no. 3 (2000): 1005–6.
  - Fernández, M. I., T. E. Wilson, K. A. Ethier, E. B. Walter, C. L. Gay, and J. Moore. “Acceptance of HIV testing during prenatal care.” Public Health Reports 115, no. 5 (2000): 460–68. https://doi.org/10.1093/phr/115.5.460.
    Full Text
  - Clements, D. A., S. P. Moreira, P. M. Coplan, C. L. Bland, and E. B. Walter. “Postlicensure study of varicella vaccine effectiveness in a day-care setting..” The Pediatric Infectious Disease Journal 18, no. 12 (December 1999): 1047–50. https://doi.org/10.1097/00006454-199912000-00004.
    Full Text
  - Frey, S., R. Dagan, Y. Ashur, X. Q. Chen, J. Ibarra, H. Kollaritsch, M. H. Mazur, et al. “Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine..” The Journal of Infectious Diseases 180, no. 6 (December 1999): 2018–22. https://doi.org/10.1086/315119.
    Full Text
  - Walter, E. B., R. B. Hornick, G. A. Poland, R. Tucker, C. L. Bland, D. A. Clements, C. C. Rhamstine, et al. “Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults..” Vaccine 17, no. 11–12 (March 1999): 1468–73. https://doi.org/10.1016/s0264-410x(98)00370-3.
    Full Text
  - Walter, E. B., and D. A. Clements. “Travel consultation for children in a university-affiliated primary care setting..” The Pediatric Infectious Disease Journal 17, no. 9 (September 1998): 841–43. https://doi.org/10.1097/00006454-199809000-00021.
    Full Text
  - Meine, E. K., S. R. Bailey, R. P. Drucker, D. A. Clements, and E. Walter. “Varicella vaccination in a primary care pediatric practice..” Archives of Pediatrics & Adolescent Medicine 152, no. 6 (June 1998): 608–9.
  - Walter, E. B., M. A. Lampe, E. Livingston, and R. A. Royce. “How do North Carolina prenatal care providers counsel and test pregnant women for HIV? Survey measures knowledge of HIV testing benefits..” North Carolina Medical Journal 59, no. 2 (March 1998): 105–9.
  - Rennels, M. B., M. J. Hohenboken, K. S. Reisinger, D. A. Clements, E. B. Walter, M. M. Blatter, J. Nonenmacher, and J. G. Hackell. “Comparison of acellular pertussis-diphtheria-tetanus toxoids and Haemophilus influenzae type b vaccines administered separately vs. combined in younger vs. older toddlers..” The Pediatric Infectious Disease Journal 17, no. 2 (February 1998): 164–66. https://doi.org/10.1097/00006454-199802000-00019.
    Full Text
  - Walter, E., J. Sung, E. Kahn Meine, R. P. Drucker, and D. A. Clements. “Lack of effectiveness of a letter reminder for annual influenza immunization of asthmatic children..” The Pediatric Infectious Disease Journal 16, no. 12 (December 1997): 1187–88. https://doi.org/10.1097/00006454-199712000-00022.
    Full Text
  - Walter, E. B., S. S. Simmons, C. L. Bland, and D. A. Clements. “Modified varicella-like syndrome in children previously vaccinated with live attenuated measles, mumps, rubella and varicella vaccine..” The Pediatric Infectious Disease Journal 16, no. 6 (June 1997): 626–27. https://doi.org/10.1097/00006454-199706000-00016.
    Full Text
  - Combs, S. P., E. B. Walter, R. P. Drucker, and D. A. Clements. “Removing a major barrier to universal hepatitis B immunization in infants..” Archives of Pediatrics & Adolescent Medicine 150, no. 1 (January 1996): 112–14. https://doi.org/10.1001/archpedi.1996.02170260116024.
    Full Text
  - Clements, D. A., C. B. Armstrong, A. M. Ursano, M. M. Moggio, E. B. Walter, and C. M. Wilfert. “Over five-year follow-up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents..” The Pediatric Infectious Disease Journal 14, no. 10 (October 1995): 874–79.
  - Clements, D. A., L. Langdon, C. Bland, and E. Walter. “Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care..” Archives of Pediatrics & Adolescent Medicine 149, no. 10 (October 1995): 1113–17. https://doi.org/10.1001/archpedi.1995.02170230067009.
    Full Text
  - Jones, S. E., C. B. Armstrong, C. Bland, E. B. Walter, and D. A. Clements. “Varicella prevalence in day-care centers..” The Pediatric Infectious Disease Journal 14, no. 5 (May 1995): 404–5.
  - Walter, E. B., A. J. Elliott, A. N. Regan, R. P. Drucker, D. A. Clements, and C. M. Wilfert. “Maternal acceptance of voluntary human immunodeficiency virus antibody testing during the newborn period with the Guthrie card..” The Pediatric Infectious Disease Journal 14, no. 5 (May 1995): 376–81.
  - Walter, E. B., S. L. Katz, and W. J. Bellini. “Measles immunity in HIV-infected children..” Pediatric Aids and Hiv Infection 5, no. 5 (October 1994): 300–304.
  - Walter, E. B., S. S. Simmons, and D. A. Clements. “Anti-polyribosylribitol phosphate antibody levels 5 years after a primary series of Haemophilus influenzae type B conjugate vaccine..” The Journal of Infectious Diseases 170, no. 4 (October 1994): 1050–51. https://doi.org/10.1093/infdis/170.4.1050.
    Full Text
  - Walter, E. B., R. P. Drucker, and D. A. Clements. “A major barrier to universal hepatitis B immunization of infants..” Archives of Pediatrics & Adolescent Medicine 148, no. 5 (May 1994): 538–39. https://doi.org/10.1001/archpedi.1994.02170050096023.
    Full Text
  - Comeau, A. M., H. W. Hsu, M. Schwerzler, G. Mushinsky, E. Walter, L. Hofman, and G. F. Grady. “Identifying human immunodeficiency virus infection at birth: application of polymerase chain reaction to Guthrie cards..” The Journal of Pediatrics 123, no. 2 (August 1993): 252–58. https://doi.org/10.1016/s0022-3476(05)81697-x.
    Full Text
  - Walter, E. B., K. J. Weinhold, and C. M. Wilfert. “Enhanced p24 antigen detection in sera from human immunodeficiency virus-infected children..” The Pediatric Infectious Disease Journal 12, no. 1 (January 1993): 94–96.
  - Maxeiner, H. G., K. O. Habermehl, T. Grünewald, and B. Ruf. “HIV-1 sensitivity to zidovudine and clinical outcome..” Lancet (London, England) 339, no. 8793 (March 1992): 626–27.
  - Tudor-Williams, G., M. H. St Clair, R. E. McKinney, M. Maha, E. Walter, S. Santacroce, M. Mintz, K. O’Donnell, T. Rudoll, and C. L. Vavro. “HIV-1 sensitivity to zidovudine and clinical outcome in children..” Lancet (London, England) 339, no. 8784 (January 1992): 15–19. https://doi.org/10.1016/0140-6736(92)90140-x.
    Full Text
  - WALTER, E. B., R. P. DRUCKER, R. E. MCKINNEY, and C. M. WILFERT. “MYOPATHY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN RECEIVING LONG-TERM ZIDOVUDINE THERAPY.” Journal of Pediatrics 119, no. 1 (July 1991): 152–55. https://doi.org/10.1016/S0022-3476(05)81057-1.
    Full Text Link to Item
  - Walter, E. B., R. P. Drucker, R. E. McKinney, and C. M. Wilfert. “Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy..” The Journal of Pediatrics 119, no. 1 Pt 1 (July 1991): 152–55. https://doi.org/10.1016/s0022-3476(05)81057-1.
    Full Text
  - Walter, Emmanuel B., Robert P. Drucker, Ross E. McKinney, and Catherine M. Wilfert. “Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.” The Journal of Pediatrics 119, no. 1 (July 1991): 152–55. https://doi.org/10.1016/s0022-3476(05)81057-1.
    Full Text
  - MCKINNEY, R. E., E. B. WALTER, G. TUDORWILLIAMS, S. L. KATZ, A. AUSTIN, and C. M. WILFERT. “CD-4+ LYMPHOCYTES IN CHILDREN UNDER 2-YEARS OLD - ESTABLISHMENT OF NORMAL VALUES IN A POPULATION AT RISK FOR HIV AND PROGNOSTIC APPLICATION TO INFECTED CHILDREN.” Pediatric Research 29, no. 4 (April 1, 1991): A178–A178.
    Link to Item
  - MCKINNEY, R. E., E. NOZIK, E. B. WALTER, G. TUDORWILLIAMS, S. L. KATZ, and C. M. WILFERT. “HEMATOLOGIC ABNORMALITIES IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTED CHILDREN AND NONINFECTED BUT HIV ANTIBODY POSITIVE CONTROLS.” Pediatric Research 29, no. 4 (April 1, 1991): A178–A178.
    Link to Item
  - Walter, E. B., R. P. Drucker, R. E. McKinney, and C. M. Wilfert. “Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.” The Journal of Pediatrics 119, no. 1 PART 1 (January 1, 1991): 152–55. https://doi.org/10.1016/S0022-3476(05)81057-1.
    Full Text
  - Walter, E. B., M. V. Moggio, R. P. Drucker, and C. M. Wilfert. “Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease..” The Pediatric Infectious Disease Journal 9, no. 9 (September 1990): 632–35.
  - Walter, E. B., R. E. McKinney, B. A. Lane, K. J. Weinhold, and C. M. Wilfert. “Interpretation of western blots of specimens from children infected with human immunodeficiency virus type 1: implications for prognosis and diagnosis..” The Journal of Pediatrics 117, no. 2 Pt 1 (August 1990): 255–58. https://doi.org/10.1016/s0022-3476(05)80540-2.
    Full Text
  - Walter, E. B., J. L. Gingras, and R. E. McKinney. “Systemic Torulopsis glabrata infection in a neonate..” Southern Medical Journal 83, no. 7 (July 1990): 837–38.
  - Walter, E. B., R. E. McKinney, B. A. Lane, K. J. Weinhold, and C. M. Wilfert. “Interpretation of Western blots of specimens from children infected with human immunodeficiency virus type 1: Implications for prognosis and diagnosis.” The Journal of Pediatrics 117, no. 2 PART 1 (January 1, 1990): 255–58. https://doi.org/10.1016/S0022-3476(05)80540-2.
    Full Text
  - Walter, E. “Vertical transmission of Citrobacter diversus from mother to infant..” The Pediatric Infectious Disease Journal 7, no. 9 (September 1988).
- Other Articles
  - “Seroprevalence of human immunodeficiency virus infection at sentinel hospitals..” The New England Journal of Medicine, December 1990. https://doi.org/10.1056/nejm199012273232615.
    Full Text
  - McKinney, R. E., P. A. Pizzo, G. B. Scott, W. P. Parks, M. A. Maha, S. N. Lehrman, M. Riggs, et al. “Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients.” The Journal of Pediatrics, January 1, 1990. https://doi.org/10.1016/S0022-3476(05)81619-1.
    Full Text
- Conference Papers
  - Edwards, J. M., N. Watson, C. Focht, C. Wynn, C. A. Todd, E. B. Walter, R. Phillips Heine, and G. K. Swamy. “Group B Streptococcus (GBS) Colonization and Disease among Pregnant Women: A Historical Cohort Study.” In Infectious Diseases in Obstetrics and Gynecology, Vol. 2019, 2019. https://doi.org/10.1155/2019/5430493.
    Full Text
  - Brady, Allison M., Emmanuel B. Walter, Lauri E. Markowitz, Elizabeth R. Unger, and Gitika Panicker. “Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity.” In Journal of Immunology, Vol. 196. AMER ASSOC IMMUNOLOGISTS, 2016.
    Link to Item
  - Fortner, Kimberly B., Kathryn M. Edwards, Karen R. Broder, Natalia Jimenez, Yuwei Zhu, Emmanuel B. Walter, Robert P. Heine, Pedro Moro, Jennifer L. Liang, and Geeta K. Swamy. “343: Reactogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women.” In American Journal of Obstetrics and Gynecology, 214:S193–94. Elsevier BV, 2016. https://doi.org/10.1016/j.ajog.2015.10.383.
    Full Text
  - Shaheen, A. W., T. Palker, E. B. Walter, J. A. Galanko, N. J. Shaheen, and R. J. Dolor. “Prescription medication sharing in primary care..” In Journal of General Internal Medicine, 19:197–197. BLACKWELL PUBLISHING INC, 2004.
    Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

In the News

Selected Grants

Selected Publications

Academic Articles

Other Articles

Conference Papers